Harte-Hanks (HHS) Misses Q3 EPS by 20c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.30 +53.02%
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Total operating expenses: 102M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Harte-Hanks (NASDAQ: HHS) reported Q3 EPS of $0.02, $0.20 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $47.63 million versus the consensus estimate of $47.2 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Reiterated at Market Outperform by Citizens on Pipeline Development
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
- Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
